Journal of Vasculitis

Department of Vasculitis, University of Charlotte, 9201 University City Blvd, Charlotte, NC 28223, USA

Publications

• Mini Review   
  Treatment Strategies for ANCA-associated Vasculitis: Recent Breakthroughs
  Author(s): Alfred Jacob*
  
  ANCA-associated vasculitis is a group of autoimmune diseases characterized by inflammation of small blood vessels, primarily affecting the kidneys and lungs. Over the years, advances in the understanding of AAV and the development of targeted therapies have significantly improved patient outcomes. This article explores the latest breakthroughs in the treatment of AAV, including novel medications and innovative approaches that are reshaping the landscape of care for individuals living with these challenging autoimmune diseases. The cornerstone of AAV treatment involves immunosuppressive drugs like corticosteroids and cyclophosphamide. These medications help suppress the autoimmune response, reduce inflammation, and prevent further tissue damage. Rituximab, a monoclonal antibody that depletes B cells, has emerged as a game-changer in AAV treatment. It has proven .. Read More»
  DOI: 10.37421/2471-9544.2023.9.206

  Abstract HTML PDF